Cargando…

Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis

BACKGROUND: A lack of clarity exists regarding contraceptive uptake and counselling among women with cancer, despite these women having unique family planning needs. This study aimed to systematically review the available literature and produce an overall summary estimate of contraceptive use and co...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Melissa L., Feyissa, Tesfaye R., Bowden, Nikola A., Gemzell-Danielsson, Kristina, Loxton, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759910/
https://www.ncbi.nlm.nih.gov/pubmed/36528586
http://dx.doi.org/10.1186/s12916-022-02690-w
_version_ 1784852337831968768
author Harris, Melissa L.
Feyissa, Tesfaye R.
Bowden, Nikola A.
Gemzell-Danielsson, Kristina
Loxton, Deborah
author_facet Harris, Melissa L.
Feyissa, Tesfaye R.
Bowden, Nikola A.
Gemzell-Danielsson, Kristina
Loxton, Deborah
author_sort Harris, Melissa L.
collection PubMed
description BACKGROUND: A lack of clarity exists regarding contraceptive uptake and counselling among women with cancer, despite these women having unique family planning needs. This study aimed to systematically review the available literature and produce an overall summary estimate of contraceptive use and counselling among women with cancer across the cancer care continuum. METHODS: A systematic search of articles reporting on contraceptive counselling and/or contraceptive use among women of reproductive age (15–49 years) with cancer across the cancer care continuum (e.g. diagnosis, treatment, survivorship) was conducted in MEDLINE, Embase, CINAHL, Maternity and Infant Care and Cochrane Library. Two independent reviewers conducted the data screening, data extraction and risk of bias assessment. Qualitative synthesis and meta-analyses were conducted to summarise the key findings. RESULTS: We included 21 articles involving 3835 participants in this review. Studies varied according to the cancer population and time along the cancer care continuum it was assessed. Of the studies that reported the overall contraceptive prevalence among women diagnosed with cancer (n = 8), contraceptive use ranged from 25 to 92%. Of the four studies that focused on cancer survivors, the contraceptive prevalence ranged from 47 to 84%. When the prevalence of these studies was pooled, a crude summary prevalence of 64% (62% among women with cancer versus 68% among cancer survivors) was found. The rate of contraceptive counselling was assessed in ten studies. A pooled prevalence of 50% (44% among women with cancer versus 58% among cancer survivors) was found, with the prevalence ranging from 12 to 78% among individual studies depending on the point in the cancer care continuum that it was provided. When contraceptive counselling was provided, it was found to significantly increase contraceptive use although biases were identified in its application. CONCLUSIONS: Contraceptive counselling interventions as part of standard cancer care have the potential to not only empower women with cancer and cancer survivors to make informed choices regarding their reproductive health but also provide the ability to plan future pregnancies for times of better health. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02690-w.
format Online
Article
Text
id pubmed-9759910
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97599102022-12-19 Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis Harris, Melissa L. Feyissa, Tesfaye R. Bowden, Nikola A. Gemzell-Danielsson, Kristina Loxton, Deborah BMC Med Research Article BACKGROUND: A lack of clarity exists regarding contraceptive uptake and counselling among women with cancer, despite these women having unique family planning needs. This study aimed to systematically review the available literature and produce an overall summary estimate of contraceptive use and counselling among women with cancer across the cancer care continuum. METHODS: A systematic search of articles reporting on contraceptive counselling and/or contraceptive use among women of reproductive age (15–49 years) with cancer across the cancer care continuum (e.g. diagnosis, treatment, survivorship) was conducted in MEDLINE, Embase, CINAHL, Maternity and Infant Care and Cochrane Library. Two independent reviewers conducted the data screening, data extraction and risk of bias assessment. Qualitative synthesis and meta-analyses were conducted to summarise the key findings. RESULTS: We included 21 articles involving 3835 participants in this review. Studies varied according to the cancer population and time along the cancer care continuum it was assessed. Of the studies that reported the overall contraceptive prevalence among women diagnosed with cancer (n = 8), contraceptive use ranged from 25 to 92%. Of the four studies that focused on cancer survivors, the contraceptive prevalence ranged from 47 to 84%. When the prevalence of these studies was pooled, a crude summary prevalence of 64% (62% among women with cancer versus 68% among cancer survivors) was found. The rate of contraceptive counselling was assessed in ten studies. A pooled prevalence of 50% (44% among women with cancer versus 58% among cancer survivors) was found, with the prevalence ranging from 12 to 78% among individual studies depending on the point in the cancer care continuum that it was provided. When contraceptive counselling was provided, it was found to significantly increase contraceptive use although biases were identified in its application. CONCLUSIONS: Contraceptive counselling interventions as part of standard cancer care have the potential to not only empower women with cancer and cancer survivors to make informed choices regarding their reproductive health but also provide the ability to plan future pregnancies for times of better health. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-022-02690-w. BioMed Central 2022-12-17 /pmc/articles/PMC9759910/ /pubmed/36528586 http://dx.doi.org/10.1186/s12916-022-02690-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Harris, Melissa L.
Feyissa, Tesfaye R.
Bowden, Nikola A.
Gemzell-Danielsson, Kristina
Loxton, Deborah
Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis
title Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis
title_full Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis
title_fullStr Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis
title_full_unstemmed Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis
title_short Contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis
title_sort contraceptive use and contraceptive counselling interventions for women of reproductive age with cancer: a systematic review and meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9759910/
https://www.ncbi.nlm.nih.gov/pubmed/36528586
http://dx.doi.org/10.1186/s12916-022-02690-w
work_keys_str_mv AT harrismelissal contraceptiveuseandcontraceptivecounsellinginterventionsforwomenofreproductiveagewithcancerasystematicreviewandmetaanalysis
AT feyissatesfayer contraceptiveuseandcontraceptivecounsellinginterventionsforwomenofreproductiveagewithcancerasystematicreviewandmetaanalysis
AT bowdennikolaa contraceptiveuseandcontraceptivecounsellinginterventionsforwomenofreproductiveagewithcancerasystematicreviewandmetaanalysis
AT gemzelldanielssonkristina contraceptiveuseandcontraceptivecounsellinginterventionsforwomenofreproductiveagewithcancerasystematicreviewandmetaanalysis
AT loxtondeborah contraceptiveuseandcontraceptivecounsellinginterventionsforwomenofreproductiveagewithcancerasystematicreviewandmetaanalysis